Discovery of ruthenium(ii) metallocompound and olaparib synergy for cancer combination therapy
Synergistic drug combinations can extend the use of poly(ADP-ribose) polymerase inhibitors (PARPi) such as Olaparib to BRCA-proficient tumors and overcome acquired or de novo drug resistance. To identify new synergistic combinations for PARPi, we screened a “micro-library” comprising a mix of commer...
| Main Authors: | Yusoh, Nur Aininie, Tiley, Paul R., James, Steffan D., Harun, Siti Norain, Thomas, Jim A., Saad, Norazalina, Ling, Wei Hii, Suet, Lin Chia, Gill, Martin R., Ahmad, Haslina |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
American Chemical Society
2023
|
| Online Access: | http://psasir.upm.edu.my/id/eprint/107358/ http://psasir.upm.edu.my/id/eprint/107358/1/107358.pdf |
Similar Items
Synergy of ruthenium metallo-intercalator, [Ru(dppz)2(PIP)]2+, with PARP inhibitor Olaparib in non-small cell lung cancer cells
by: Yusoh, Nur Aininie, et al.
Published: (2023)
by: Yusoh, Nur Aininie, et al.
Published: (2023)
PARP inhibitor combinations with Olaparib for synergistic efficacy in Olaparib-resistant triple-negative breast cancer cells
by: Yusoh, Nur Aininie
Published: (2023)
by: Yusoh, Nur Aininie
Published: (2023)
Combining PARP inhibition with platinum, ruthenium or gold complexes for cancer therapy
by: Yusoh, Nur Aininie, et al.
Published: (2020)
by: Yusoh, Nur Aininie, et al.
Published: (2020)
Effect of combination therapy of ruthenium polypyridyl complex, [Ru(dppz)2(PIP)]2+ and parp inhibitors against several cancer cell lines
by: Yusoh, Nur Aininie
Published: (2020)
by: Yusoh, Nur Aininie
Published: (2020)
Synthesis and optimization of mesoporous silica nanoparticles for ruthenium polypyridyl drug delivery
by: Harun, Siti Norain, et al.
Published: (2021)
by: Harun, Siti Norain, et al.
Published: (2021)
Ruthenium(II) Polypyridyl Complexes as FRET donors: structure- and sequence-selective DNA-binding and anticancer properties
by: Elgar, Christopher E., et al.
Published: (2023)
by: Elgar, Christopher E., et al.
Published: (2023)
Ruthenium(ii) Polypyridyl complexes as FRET donors: structure- and sequence-selective DNA binding and anti-cancer properties
by: E. Elgar, Christopher, et al.
Published: (2023)
by: E. Elgar, Christopher, et al.
Published: (2023)
Synthesis, cytotoxicity and dna binding studies of ruthenium(ii) mixed-polypyridyl complexes
by: Harun, Siti Norain
Published: (2015)
by: Harun, Siti Norain
Published: (2015)
A ruthenium polypyridyl intercalator stalls DNA replication forks, radiosensitizes human cancer cells and is enhanced by Chk1 inhibition
by: Gill, Martin R., et al.
Published: (2016)
by: Gill, Martin R., et al.
Published: (2016)
Arene ruthenium chemistry
by: Bates, Richard Simon
Published: (1990)
by: Bates, Richard Simon
Published: (1990)
Metallointercalator [Ru(dppz)2(PIP)]2+ renders BRCA wild-type triple-negative breast cancer cells hypersensitive to PARP inhibition
by: Yusoh, Nur Aininie, et al.
Published: (2020)
by: Yusoh, Nur Aininie, et al.
Published: (2020)
Electrochemical DNA biosensor for detection of porcine oligonucleotides using ruthenium(II) complex as intercalator label redox
by: Abdullah Halid, Nurul Izni, et al.
Published: (2014)
by: Abdullah Halid, Nurul Izni, et al.
Published: (2014)
Fabrication of porcine DNA biosensor based on ruthenium bipyridine complex
by: Abdullah Halid, Nurul Izni, et al.
Published: (2016)
by: Abdullah Halid, Nurul Izni, et al.
Published: (2016)
Phase I trial of the oral PARP inhibitor olaparib in combination with paclitaxel for first- or second-line treatment of patients with metastatic triple-negative breast cancer
by: Dent, R., et al.
Published: (2013)
by: Dent, R., et al.
Published: (2013)
Strategic alliances and knowledge sharing: synergies or silos?
by: Connell, Julia, et al.
Published: (2007)
by: Connell, Julia, et al.
Published: (2007)
Elastic properties and lattice dynamics of ruthenium at high pressures
by: Lugovskoy, Andrey, et al.
Published: (2014)
by: Lugovskoy, Andrey, et al.
Published: (2014)
Dichlorido(η6-p-cymene)[tris(2-cyanoethyl)phosphine]ruthenium(II)
by: Henderson, William, et al.
Published: (2018)
by: Henderson, William, et al.
Published: (2018)
Pulsed Nd:YAG Laser Deposition Of Ruthenium Thin Films
by: Lee , Wai Keat
Published: (2010)
by: Lee , Wai Keat
Published: (2010)
Stability of the hcp Ruthenium at high pressures from first principles
by: Lugovskoy, Andrey, et al.
Published: (2014)
by: Lugovskoy, Andrey, et al.
Published: (2014)
Creation of Synergies Through Mergers and Acquisitions
by: Kedia, Vasudha
Published: (2007)
by: Kedia, Vasudha
Published: (2007)
Scientific synergy between LSST and Euclid
by: Rhodes, Jason, et al.
Published: (2017)
by: Rhodes, Jason, et al.
Published: (2017)
Australian Businesses in China: Searching for synergy
by: Whiteley, Alma, et al.
Published: (2003)
by: Whiteley, Alma, et al.
Published: (2003)
Formation of New MPP Leadership Synergy
by: UMP, PNC
Published: (2019)
by: UMP, PNC
Published: (2019)
Synergy on ontology and data mining: increasing value of the mental health
by: Hadzic, Maja, et al.
Published: (2008)
by: Hadzic, Maja, et al.
Published: (2008)
On-Surface Azide-Alkyne Cycloaddition Reaction: Does It Click with Ruthenium Catalysts?
by: Li, Tiexin, et al.
Published: (2022)
by: Li, Tiexin, et al.
Published: (2022)
Heterogeneous activation of peroxymonosulphate by supported ruthenium catalysts for phenol degradation in water
by: Muhammad, Syaifullah, et al.
Published: (2012)
by: Muhammad, Syaifullah, et al.
Published: (2012)
Facile Decarboxylation of Propiolic Acid on a Ruthenium Center and Related Chemistry
by: Bowie, J., et al.
Published: (2012)
by: Bowie, J., et al.
Published: (2012)
Heterogeneous catalytic oxidation of phenol for wastewater treatment using Ruthenium Catalyst
by: Muhammad, Syaifullah, et al.
Published: (2011)
by: Muhammad, Syaifullah, et al.
Published: (2011)
The interface between adaptive and innate neutralisation of virus entry: competition, addition or synergy?
by: Wartnaby, Sophie R.
Published: (2023)
by: Wartnaby, Sophie R.
Published: (2023)
SYNERGIES FROM MERGERS AND ACQUISITIONS: CASE STUDIES
by: Alexander, Joby
Published: (2006)
by: Alexander, Joby
Published: (2006)
Global Hydrogen Market Prospects and Synergies with LNG
by: Aguilera, Roberto F.
Published: (2019)
by: Aguilera, Roberto F.
Published: (2019)
Global Hydrogen Market Prospects and Synergies with LNG
by: Aguilera, Roberto F.
Published: (2019)
by: Aguilera, Roberto F.
Published: (2019)
UMPSA synergy expands Technology-Focused TVET
by: Nor Salwana, Mohammad Idris
Published: (2024)
by: Nor Salwana, Mohammad Idris
Published: (2024)
Synthesis, characterization and DNA binding studies of luminescent ruthenium(ii) imidazo complexes
by: Ting, Timothy Tze Chun
Published: (2014)
by: Ting, Timothy Tze Chun
Published: (2014)
The synergy between human factors and risk attitudes of Malaysian contractors’: Moderating effect of government policy
by: Taofeeq, D. M., et al.
Published: (2020)
by: Taofeeq, D. M., et al.
Published: (2020)
Synergies and Value Creation : The Perspective of Participants in Mergers and Acquisitions
by: Suleymanova, Zarina
Published: (2014)
by: Suleymanova, Zarina
Published: (2014)
Design computing: A new challenge for creative synergy
by: Rafi , A.
Published: (2001)
by: Rafi , A.
Published: (2001)
Exploring 21 cm-Lya Emitter Synergies for SKA
by: Hutter, A., et al.
Published: (2017)
by: Hutter, A., et al.
Published: (2017)
Global Hydrogen Market Prospects: Synergies with Gas and LNG
by: Aguilera, Roberto F.
Published: (2019)
by: Aguilera, Roberto F.
Published: (2019)
A framework for synergy evaluation and development in heavy industries
by: Mohammed, Feisal, et al.
Published: (2013)
by: Mohammed, Feisal, et al.
Published: (2013)
Similar Items
-
Synergy of ruthenium metallo-intercalator, [Ru(dppz)2(PIP)]2+, with PARP inhibitor Olaparib in non-small cell lung cancer cells
by: Yusoh, Nur Aininie, et al.
Published: (2023) -
PARP inhibitor combinations with Olaparib for synergistic efficacy in Olaparib-resistant triple-negative breast cancer cells
by: Yusoh, Nur Aininie
Published: (2023) -
Combining PARP inhibition with platinum, ruthenium or gold complexes for cancer therapy
by: Yusoh, Nur Aininie, et al.
Published: (2020) -
Effect of combination therapy of ruthenium polypyridyl complex, [Ru(dppz)2(PIP)]2+ and parp inhibitors against several cancer cell lines
by: Yusoh, Nur Aininie
Published: (2020) -
Synthesis and optimization of mesoporous silica nanoparticles for ruthenium polypyridyl drug delivery
by: Harun, Siti Norain, et al.
Published: (2021)